A bacteriophage, designated pVp-1, showed effective infectivity for multiple-antibiotic–resistant
V. parahaemolyticus and V. vulnificus, including V. parahaemolyticus pandemic strains. The therapeutic potential
of the phage was studied in a mouse model of experimental infection using a multiple-antibiotic–resistant V. parahaemolyticus
pandemic strain.